查詢結果分析
相關文獻
- Epidermal Growth Factor Expression in Middle Ear Cholesteatoma
- Evaluation of Proliferative Activity in Middle Ear Cholesteatoma Using Proliferating Cell Nuclear Antigen
- 中耳膽脂瘤
- 母乳中所含細胞增殖因子與IgA、IgG免疫球蛋白的研究
- Effects of Epidermal Growth Factor on Total Cellular RNA, Protein and Leucine Aminopeptidase in Human Colon Adenocarcinoma (Caco-2) Cells
- Management of Labyrinthine Fistula in Middle Ear Cholesteatoma
- Expression of Epidermal Growth Factor Receptor in Human Middle Ear Cholesteatoma
- 中耳膽脂瘤
- 基因醫學在臨床腫瘤學的應用
- Treatment Outcome in Women with Operable HER2-positive Breast Cancer: A Single Institutional Report
頁籤選單縮合
題名 | Epidermal Growth Factor Expression in Middle Ear Cholesteatoma=中耳膽脂瘤之上皮細胞生長因子的表現 |
---|---|
作者 | 紀宏彬; 何坤瑤; 蔡志仁; 王凌峰; 戴志峰; 李家和; 郭文烈; 吳淑釧; 蔡世盟; | 書刊名 | The Kaohsiung Journal of Medical Sciences |
卷期 | 20:1 2004.01[民93.01] |
頁次 | 頁6-11 |
分類號 | 416.821 |
關鍵詞 | 上皮生長因子; 中耳膽脂瘤; Epidermal growth factor; Middle ear cholesteatoma; |
語文 | 英文(English) |
中文摘要 | 中耳膽脂瘤在臨床上對於中耳裂具有相當的破壞性,而治療上通常必須藉手術清除中耳腔所有的膽脂瘤上皮成分。上皮細胞生長因子 (epidermal growth factor, EGF) 是一種含有 53 個氨基酸所組成的單鍵醣蛋白。 EGF 能夠刺激及分化不同的哺乳動物細胞,如表皮細胞、纖維母細胞及內皮細胞等。本研究利用免疫組織化學酵素抗體法 (avidin-biotin-peroxidase complex) 以 EGF 單株抗體免疫染色,評估比較 40 例膽脂瘤與 34 例正常耳廓後皮膚兩者之組織內表皮、纖維母細胞及內皮細胞 EGF 陽性細胞之分佈表現。在中耳膽脂瘤組織細胞中, EGF 陽性百分比在 squamous epithelium、endothelium 及 fibroblast 細胞分別為 53% (21 例)、5% (2 例) 及 5% (2 例);而在耳廓後皮膚組織中,其陽性率分別為 41% (14例)、0% (0 例) 及3% (1 例)。利用卡方檢定 EGF 陽性細胞於各類型細胞之表現比率,兩組間並無統計學上的差異,本研究結果顯示上皮細胞生長因子在膽脂瘤中並無異常排列,而且膽脂瘤的進展可能與其本身或與周圍發炎組織所釋放生長因子的複雜相關作用機制有關。 |
英文摘要 | Middle ear cholesteatoma is destructive to auditory ossicles and temporal bone, and treatment usually requires surgical removal of all epithelial content. Epidermal growth factor (EGF) can stimulate the growth and differentiation of a variety of mammalian cells, including epithelial cells. Our study used the avidin-biotin complex technique to evaluate the expression of EGF in 40 cases of middle ear cholesteatoma (active cholesteatoma, 31 cases; inactive cholesteatoma, 9 cases) and 34 normal postauricular skin samples. In middle ear cholesteatoma, EGF was expressed in squamous epithelium in 21 cases (53%), fibroblasts in two cases (5%), and cholesteatoma endothelium in two cases (5%). In normal postauricular skin, EGF was expressed in squamous epithelium in 14 samples (41%), fibroblasts in one sample (3%), and endothelium in none. No statistical difference in EGF expression was found between cholesteatoma and normal postauricular skin samples. These results show that the distribution of EGF in middle ear cholesteatoma is not deranged and that the progression of cholesteatoma might be induced by the release of factors from the cholesteatoma matrix via autocrine stimulation, or by inflammatory cells of the subepithelial tissue through paracrine stimulation, or in both of these ways. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。